IceCure Medical (NASDAQ:ICCM) Earns Buy Rating from HC Wainwright

HC Wainwright reissued their buy rating on shares of IceCure Medical (NASDAQ:ICCM – Free Report) in a research note published on Thursday, Benzinga reports. They currently have a $3.00 target price on the stock. Separately, Alliance Global Partners increased their price target on shares of IceCure Medical from $1.90 to $2.90 and gave the stock […]

Related Keywords

United States ,America , ,Nasdaq ,Jpmorgan Chase Co ,Boothbay Fund Management ,America Corp ,Icecure Medical Company Profile ,Icecure Medical Ltd ,Alliance Global Partners ,Icecure Medical ,Free Report ,Cure Medical ,Get Free Report ,Fund Management ,Cure Medical Ltd ,Icecure Medical Daily ,